513-529
ENS TEACHING REVIEW
The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis
Aksel Siva and Sabahattin Saip
530-538
REVIEW
Transcranial duplex in the differential diagnosis of parkinsonian syndromes
A systematic review
Annemarie M. M. Vlaar, Angela Bouwmans, Werner H. Mess, Selma C. Tromp and Wim E. J. Weber
539-553
REVIEW
Recent advances in the diagnosis, genetics and treatment of restless legs syndrome
Claudia Trenkwalder, Birgit Högl and Juliane Winkelmann
554-562
ORIGINAL COMMUNICATION
Multiple sclerosis patients—benefit-risk preferences: Serious adverse event risks versus treatment efficacy
F. Reed Johnson, George Van Houtven, Semra Özdemir, Steve Hass and Jeff White, et al.
563-567
ORIGINAL COMMUNICATION
Long-lasting benefits of botulinum toxin type B in Parkinson’s disease-related drooling
Giovanni Lagalla, Marzia Millevolte, Marianna Capecci, Leandro Provinciali and Maria Gabriella Ceravolo
568-576
ORIGINAL COMMUNICATION
Factors that influence adherence with disease-modifying therapy in MS
Katherine Treadaway, Gary Cutter, Amber Salter, Sharon Lynch and James Simsarian, et al.
577-585
ORIGINAL COMMUNICATION
Smoking is associated with progressive disease course and increased progression in clinical disability in a prospective cohort of people with multiple sclerosis
Fotini Pittas, Anne-Louise Ponsonby, Ingrid A. F. van der Mei, Bruce V. Taylor and Leigh Blizzard, et al.
586-590
ORIGINAL COMMUNICATION
Serum S-100B protein levels in patients with herpes simplex encephalitis and tick-borne encephalitis — A marker of CNS damage during the initial stage of disease
Marie Studahl, Göran Günther and Lars Rosengren
591-599
ORIGINAL COMMUNICATION
Clinical determinants of infarct pattern subtypes in large vessel atherosclerotic stroke
Oh Young Bang, Bruce Ovbiagele, David S. Liebeskind, Lucas Restrepo and Sa Rah Yoon, et al.
600-607
ORIGINAL COMMUNICATION
Open AccessDelusions in frontotemporal lobar degeneration
Rohani Omar, Elizabeth L. Sampson, Clement T. Loy, Catherine J. Mummery and Nick C. Fox, et al.
608-614
ORIGINAL COMMUNICATION
IVIg dose increase in multifocal motor neuropathy
A prospective six month follow-up
Andreas Baumann, Christian W. Hess and Matthias Sturzenegger
615-619
ORIGINAL COMMUNICATION
CSF neurofilament protein analysis in the differential diagnosis of ALS
Thierry S. Reijn, Wilson F. Abdo, Helenius J. Schelhaas and Marcel M. Verbeek
620-624
ORIGINAL COMMUNICATION
Entrapment in anti myelin-associated glycoprotein neuropathy
Catharina G. Faber, Nicolette C. Notermans, John H. J. Wokke and Hessel Franssen
625-631
ORIGINAL COMMUNICATION
Serum free hemoglobin as a novel potential biomarker for acute ischemic stroke
Poyin Huang, Li-Hua Lo, Yin-Chun Chen, Ruey-Tay Lin and Jentaie Shiea, et al.
632-638
ORIGINAL COMMUNICATION
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia
Gabriella Santangelo, Carmine Vitale, Luigi Trojano, Katia Longo and Autilia Cozzolino, et al.
639-644
ORIGINAL COMMUNICATION
Long-term mortality and risk of stroke after transient ischemic attack
A hospital-based cohort study
Christian Weimar, Jens Benemann, Roman Huber, Thomas Mieck and Stephen Kaendler, et al.
645-650
ORIGINAL COMMUNICATION
Modafinil effects in multiple sclerosis patients with fatigue
Rüdiger Lange, Marek Volkmer, Christoph Heesen and Joachim Liepert
651-656
ORIGINAL COMMUNICATION
Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke
A proof-of-concept study
Sergio Amaro, Víctor Obach, Alvaro Cervera, Xabier Urra and Manuel Gómez-Choco, et al.
657-659
LETTER TO THE EDITORS
Erectile dysfunction in myotonic dystrophy type 1 (DM1)
Giovanni Antonini, Alessandro Clemenzi, Elisabetta Bucci, Stefania Morino and Matteo Garibaldi, et al.
660-661
LETTER TO THE EDITORS
Tolosa-Hunt syndrome responsive to infliximab therapy
Ged O’Connor and Michael Hutchinson
662-663
LETTER TO THE EDITORS
Restless legs syndrome induced by topiramate: Two more cases
Pedro Emilio Bermejo
664-666
LETTER TO THE EDITORS
Monocular ophthalmoplegia and partial supranuclear vertical gaze palsy due to unilateral paramedian rostral midbrain infarction
Matthew J. Thurtell, R. John Leigh and G. Michael Halmagyi
667-668
LETTER TO THE EDITORS
Secondary SUNCT syndrome caused by viral meningitis
Yasuo Ito, Toshimasa Yamamoto, Mikiko Ninomiya, Yoshikazu Mizoi and Kaori Itokawa, et al.
669-671
LETTER TO THE EDITORS
Convexity subarachnoid haemorrhage associated with bilateral internal carotid artery stenoses
Timothy John Kleinig, Thomas Edward Kimber and Philip Douglas Thompson
672-673
LETTER TO THE EDITORS
A novel mutation as a cause of L-2-hydroxyglutaric aciduria
Ged O’Connor, M. King, G. Salomons, C. Jakobs and O. Hardiman
674-675
LETTER TO THE EDITORS
Cyclosporine-induced parkinsonism
Marco A. Lima, Simone Maradei and Pericles Maranhao Filho
676-678
LETTER TO THE EDITORS
Amyloid myopathy with external ophthalmoparesis
Akihiko Hoshi, Masahiro Ebitani, Gaku Tanaka, Kouichirou Nakamura and Ken Shibano, et al.
679-682
LETTER TO THE EDITORS
An infantile case of Alexander disease unusual for its MRI features and a GFAP allele carrying both the p.Arg79His mutation and the p.Glu223Gln coding variant
Maria Teresa Dotti, Rosaria Buccoliero, Andrew Lee, J. Raphael Gorospe and Daniel Flint, et al.
683-684
PIONEERS IN NEUROLOGY
Karl-Axel Ekbom (1907–1977)
Elias Karroum, E. Konofal and I. Arnulf
685-687
JOURNAL CLUB
Peripheral neuropathies: skin biopsies, neuropathic pain and the effects of rituximab
Michael Strupp
688-692
COMMUNICATIONS
Communications of the European Neurological Society